APA (7th ed.) Citation

SR, S., BF, K., R, Y., K, S., JM, S., QJ, K., . . . P, S. (2023). ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. NPJ breast cancer, 9(1), 10. https://doi.org/10.1038/s41523-023-00512-7

Chicago Style (17th ed.) Citation

SR, Stecklein, et al. "CtDNA and Residual Cancer Burden Are Prognostic in Triple-negative Breast Cancer Patients with Residual Disease." NPJ Breast Cancer 9, no. 1 (2023): 10. https://doi.org/10.1038/s41523-023-00512-7.

MLA (9th ed.) Citation

SR, Stecklein, et al. "CtDNA and Residual Cancer Burden Are Prognostic in Triple-negative Breast Cancer Patients with Residual Disease." NPJ Breast Cancer, vol. 9, no. 1, 2023, p. 10, https://doi.org/10.1038/s41523-023-00512-7.